Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study †
Titel:
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study †
Auteur:
Martin, M. Fumoleau, P. Dewar, J.A. Albanell, J. Limentani, S.A. Campone, M. Chang, J.C. Patre, M. Strasak, A. de Haas, S.L. Xu, J. Garcia-Saenz, J.A.